IN VITRO BROMODEOXYURIDINE LABELING INDEX : PROGNOSTIC ROLE IN EARLY STAGE BREAST CANCER

Abstract

AIM: Various putative prognostic factors were studied in early breast cancer to evaluate local and systemic recurrence rates and make a decision for adjuvant treatments. In this study, the prognostic value of bromodeoxyuridine labeling index (BrdU LI) has been investigated in patients with early breast cancer and compared with other established clinical and biological factors.